MENU
MBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mustang Bio (MBIO) Ownership - Who owns Mustang Bio?
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
377 Plantation Street
Phone
+1 781 652-4500
Employees
80
Web
https://www.mustangbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.97M
P/E Ratio
N/A
Total Cash
27.5M
Projected Growth
N/A
Total Debt
983K
Revenue
N/A
Risk (Beta)
2.21
Dividend Yield
N/A
Total Cash/Share
9.98
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MBIO
Capitalization
3.97M
P/E Ratio
N/A
Risk (Beta)
2.21
Dividend Yield
N/A
Total Cash
27.5M
Total Cash/Share
9.98
Total Debt
983K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-8.66M
P/B Ratio
31.75
Cash Flow
N/A
Earnings
-66.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
0.40
Current Revenue Per Employee
8333.33
Dividends Per Share - Security
N/A
EBITDA
-22.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-168.70
Shares Held By Institutions
177K
Shares Outstanding - Current
2.76M
Total Liabilities
15.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-83.729
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company which develops novel immunotherapy''s
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
377 Plantation Street
Phone
+1 781 652-4500
Employees
80
Web
https://www.mustangbio.com